| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | skepinone-L | CTRPv2 | pan-cancer | AAC | 0.13 | 0.02 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.092 | 0.02 |
| mRNA | oligomycin a | CTRPv2 | pan-cancer | AAC | 0.091 | 0.02 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | 0.096 | 0.02 |
| mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | 0.095 | 0.02 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.02 |
| mRNA | OSI-930 | GDSC1000 | pan-cancer | AAC | -0.084 | 0.02 |
| mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.02 |
| mRNA | VU0155056 | CTRPv2 | pan-cancer | AAC | 0.092 | 0.02 |